Zydus Executive and Leadership Team

Mangesh Vaze, the President, Api Business at Zydus, directs the global manufacturing and supply chain operations for active pharmaceutical ingredients. Overseeing complex chemical synthesis processes, the President, Api Business ensures compliance with stringent international regulatory standards across manufacturing sites in India and abroad. This leadership role involves optimizing production efficiency to support the broader pharmaceutical portfolio. By managing large-scale industrial operations, Mangesh Vaze drives the availability of critical raw materials for finished dosage forms. The President, Api Business coordinates with research teams to scale new chemical entities from laboratory settings to commercial production. Through rigorous quality control and supply chain management, the President, Api Business maintains the integrity of the global distribution network. Mangesh Vaze secures the operational foundation necessary for the company to meet high demand in regulated markets like the United States and Europe while sustaining growth in emerging regions.

Kapil Maithal, the President, Vaccines and Diagnostics at Zydus, architects the strategic development and commercialization of immunological products. Overseeing advanced research facilities, the President, Vaccines and Diagnostics manages the lifecycle of complex biological assets from clinical trials to market launch. This leadership role requires close collaboration with regulatory bodies to ensure safety and efficacy in diverse global markets. By focusing on innovative diagnostic tools and vaccine platforms, Kapil Maithal expands the company's footprint in preventative healthcare. The President, Vaccines and Diagnostics drives initiatives to enhance manufacturing capacity for biological products, ensuring consistent supply across South Africa and Latin America. Through the integration of cutting-edge biotechnology, the President, Vaccines and Diagnostics supports the company's mission to address unmet medical needs. Kapil Maithal maintains a focus on long-term scientific advancement, ensuring that the vaccine and diagnostic pipeline remains competitive within the rapidly evolving global pharmaceutical landscape.

Dr.Amrut Naik, the President at Zydus, oversees the strategic execution of pharmaceutical manufacturing excellence and operational efficiency. Managing cross-functional teams, the President drives the implementation of advanced manufacturing technologies to optimize production output across multiple global sites. This leadership role involves aligning industrial capabilities with the company's overarching market strategy to ensure consistent product quality. By streamlining internal processes, Dr.Amrut Naik enhances the agility of the supply chain in response to fluctuating global demand. The President coordinates with technical departments to maintain high standards of operational safety and environmental compliance. Through the oversight of large-scale manufacturing infrastructure, the President supports the delivery of a comprehensive pharmaceutical portfolio to diverse international markets. Dr.Amrut Naik ensures that operational performance remains a core pillar of the company's competitive advantage, facilitating sustainable growth and maintaining the company's reputation for reliability in the pharmaceutical sector.

Nitinkumar Parekh, the President (Special Projects) at Zydus, directs high-impact initiatives focused on organizational transformation and strategic business expansion. Overseeing complex integration efforts, the President (Special Projects) manages the execution of critical projects that align with the company's long-term growth objectives. This leadership role involves identifying and capitalizing on unique market opportunities to strengthen the company's global position. By coordinating with various departments, Nitinkumar Parekh ensures the successful implementation of initiatives that enhance operational synergy and financial performance. The President (Special Projects) evaluates emerging trends in the pharmaceutical industry to guide the development of new business models. Through the management of specialized projects, the President (Special Projects) drives innovation in internal processes and external partnerships. Nitinkumar Parekh provides the strategic oversight necessary to navigate complex market environments, ensuring that the company remains at the forefront of pharmaceutical development and distribution on a global scale.

Kacharu Toshniwal, the President at Zydus, manages the strategic oversight of regional market operations and business development. Overseeing the expansion of the company's footprint in emerging markets, the President drives initiatives to increase market penetration and brand presence. This leadership role involves analyzing regional regulatory landscapes to tailor product distribution strategies effectively. By fostering relationships with local stakeholders, the President ensures that the company's pharmaceutical offerings meet the specific needs of diverse patient populations. Kacharu Toshniwal coordinates with global sales teams to optimize revenue growth and maintain a competitive edge in international territories. Through the management of regional business units, the President supports the company's mission to provide accessible healthcare solutions. Kacharu Toshniwal directs the implementation of localized marketing and distribution tactics, ensuring that the company's global pharmaceutical portfolio achieves maximum impact across various geographic regions while maintaining consistent quality and service standards.

Harish Sadana, the President Corporate Matters at Zydus, directs the governance, legal, and compliance frameworks that underpin the company's global operations. Overseeing corporate policy, the President Corporate Matters ensures that all business activities align with international regulatory requirements and ethical standards. This leadership role involves managing complex legal risks and protecting the company's intellectual property across multiple jurisdictions. By providing strategic counsel to the board and executive leadership, Harish Sadana facilitates informed decision-making regarding corporate structure and risk management. The President Corporate Matters coordinates with external legal partners to navigate the intricacies of global pharmaceutical regulations. Through the oversight of corporate governance, the President Corporate Matters maintains the integrity of the company's operations in the United States, Europe, and beyond. Harish Sadana secures the company's legal standing, enabling the organization to pursue its mission of pharmaceutical innovation with confidence and transparency in every market served.

Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, architects the organizational culture and internal communication strategies that support the company's global workforce. Overseeing talent acquisition and development, the Group President, Human Resources & Corporate Communications ensures that the company attracts and retains the expertise necessary for pharmaceutical innovation. This leadership role involves aligning human capital strategies with the company's business goals to foster a high-performance environment. By managing corporate communications, Rishikesh Raval shapes the company's public image and ensures consistent messaging across all global channels. The Group President, Human Resources & Corporate Communications coordinates with leadership to promote employee engagement and professional growth. Through the integration of HR and communication functions, the Group President, Human Resources & Corporate Communications strengthens the company's internal cohesion and external reputation. Rishikesh Raval drives the initiatives that define the company's identity as a leading global pharmaceutical entity.